Print this page    •   Back to Web version of article

International News
UNAIDS Welcomes U.S. Approval of Drug to Stop HIV

July 18, 2012

UNAIDS on Tuesday hailed the US Food and Drug Administration's decision to approve Truvada to prevent HIV infection. The pill, which combines emtricitabine and tenofovir disoproxil fumarate, already is in use as an HIV treatment. UNAIDS noted that the new approval allows its use "to prevent the sexual transmission of HIV for people who do not have HIV, but who are at high risk of being exposed to the virus." FDA approved Truvada's use for pre-exposure prophylaxis as part of a broader HIV prevention strategy that includes condom use and other safer sex practices, risk-reduction counseling, and control of other STDs.

Back to other news for July 2012

Excerpted from:
Agence France Presse

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.